NCT05665348
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
- Locations
-
- Chu Amiens Picardie Amiens, France
- CHU Angers, France
- Privé LES BONNETTES Arras, France
- Chu Avicienne Bobigny, France
Clinical trial condition
HCC - Hepatocellular Carcinoma
Explore clinical trials studying HCC - Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
72 public trials
29 recruiting studies
HCC - Hepatocellular Carcinoma trial results
NCT06631326
- Conditions
- Adenocarcinoma, BCLC Stage C Hepatocellular Carcinoma, Carcinoma, +13 more
- Locations
-
- The first hospital of China medical university Shenyang, Liaoning, China
Completed
Real-world Study of Lenalidomide After First-line Treatment Lenvatinib With PD-1 in Advanced HCC
NCT07184424
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Beijing Tsinghua Changgung Hospital Beijing, China
NCT06991907
- Conditions
- 125I Seeds Implantation, Adenocarcinoma, Carcinoma, +10 more
- Locations
-
- Jiangxi Cancer Hospital Nanchang, Jiangxi, China
NCT06776185
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Wuhan Tongji Hospital Wuhan, Hubei, China
NCT06760494
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- the First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
- Chinese PLA General Hospital Beijing, China
NCT06437457
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
Active, Not Recruiting
Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI
NCT07658105
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Active, Not Recruiting
Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma
NCT07444905
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Active, Not Recruiting
Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure
NCT06045975
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Hospitl Avicenne Bobigny, France